1/6/22
Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems
SOUTH PLAINFIELD, NJ, January 6, 2022 – South Plainfield, NJ (January 6, 2022) – Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems11/8/21
10/7/21
Azenta Life Sciences and Cleveland Clinic Celebrate Opening of Biobanking Facility
CLEVELAND, OH and CHELMSFORD, MA – October 7, 2021—Azenta Life Sciences and Cleveland Clinic have opened a new 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus. The two-story biorepository is managed by Azenta Life Sciences, Brooks' recently re-branded life sciences division, and includes ultra-cold and cryogenic storage for researchers at Cleveland Clinic and other institutions. The new facility increases biobanking capacity at Cleveland Clinic and will help accelerate translational research.9/28/21
Brooks Introduces Azenta Life Sciences to Advance Innovative Sample Solutions
Chelmsford, MA – September 28, 2021—Today Brooks Automation, Inc. (Nasdaq: BRKS) announces Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences (“Azenta”). Azenta will bring together our existing portfolio of life sciences products and services to deliver integrated enterprise-wide sample exploration and management solutions.4/6/21
1/12/21
Azenta Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute
CHELMSFORD, Mass., January 12, 2021 – Azenta Life Sciences announced today that GENEWIZ, the Company’s genomics analysis business, has been awarded one of six Genome Characterization Center Indefinite Delivery Indefinite Quantity (IDIQ) contracts from the National Cancer Institute (NCI). The NCI, the nation’s leader in cancer research and part of the National Institutes of Health (NIH), chose GENEWIZ to provide whole exome sequencing to new research projects at its Center for Cancer Genomics for a period of three years.1/7/21
Dr. Loupy, French Transplant Physician and Researcher Awarded GENEWIZ Digital Spatial Profiler Grant
South Plainfield, NJ – January 7, 2021 – Leading global genomics service provider, GENEWIZ, a Azenta Life Sciences Company, announced today that Alexandre Loupy, MD, Ph.D., Professor of Nephrology and Epidemiology at Necker Hospital, Paris, and Director of the Paris Transplant Group at Inserm, France, has been awarded the GENEWIZ Digital Spatial Profiler Grant. Dr. Loupy will be provided digital spatial profiling services on the NanoString Technologies® GeoMx™ platform for his study investigating the spatial immune response during allograft rejection.10/16/19
GENEWIZ to Introduce GeoMx™ Digital Spatial Profiler Service at ASHG 2019
South Plainfield, NJ and Houston, TX (ASHG 2019, Booth #1403) — Oct 16, 2019 – Leading global genomics service provider, GENEWIZ, a Azenta Life Sciences Company, today announced at the American Society of Human Genetics (ASHG) Conference that it will begin offering early access to morphological gene and protein expression analysis using NanoString’s GeoMx™ Digital Spatial Profiler (DSP).9/25/2019
GENEWIZ Celebrates Opening of European Headquarters in Germany
Leipzig, Germany – September 25, 2019 - Leading global genomics services provider, GENEWIZ, a Azenta Life Sciences Company, announced the opening of its European headquarters for its genomics business in Leipzig, Germany.11/15/18
Azenta Life Sciences Announces Completion of GENEWIZ Acquisition
CHELMSFORD, Mass., Nov. 15, 2018 /PRNewswire/ -- Azenta Life Sciences, a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences, announced today that it has closed its previously announced acquisition of GENEWIZ Group.10/16/18
10/16/18
GENEWIZ Introduces CLIA-compliant Next Generation Sequencing Services at ASHG
Leading global genomics service provider, GENEWIZ, announced at the American Society of Human Genetics (ASHG) Conference today that it has expanded its CLIA-compliant service offering into next generation sequencing (NGS). ASHG runs through October 20, 2018 at the San Diego Convention Center.9/26/18
GENEWIZ to be Acquired by Azenta Life Sciences
SOUTH PLAINFIELD, NJ, September 26, 2018 – GENEWIZ announced today that it has entered into a definitive agreement to be acquired by Azenta Life Sciences. GENEWIZ is a leading global genomics service provider with laboratory operations in the United States, the United Kingdom, Germany, China, and Japan.6/27/18
5/1/18
GENEWIZ Celebrates Newly Expanded International Headquarters in South Plainfield on DNA Day
South Plainfield, NJ – April 30, 2018 – Leading global genomics service provider, GENEWIZ, celebrated the grand opening of its newly expanded global headquarters on April 25 with a ribbon-cutting ceremony at its state-of-the-art office complex in South Plainfield, NJ.
4/24/18
GENEWIZ AND PACIFIC BIOSCIENCES ANNOUNCE WINNER OF THE 2017 STRUCTURAL VARIANT SMRT® GRANT PROGRAM
Menlo Park, CA and South Plainfield, NJ – Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read, high-resolution sequencing, and GENEWIZ, a leading global genomics service provider, are pleased to announce that Professor Stephen Scherer, Ph.D., Co-founder and Director of the Centre for Applied Genomics at University of Toronto’s Hospital for Sick Children and Director of the University of Toronto McLaughlin Centre, is the winner of the 2017 Structural Variant SMRT Grant.
11/30/17
GENEWIZ Honored with Two Top New Jersey Business Awards
South Plainfield, N.J. — November 2017 — Leading global genomics service provider, GENEWIZ, was recently recognized by the New Jersey Business & Industry Association’s 2017 Awards for Excellence with the Outstanding Employer Award. This comes on the heels of being named to NJBIZ’s list of the 50 Fastest Growing Companies in New Jersey for the fifth year in the row.
11/15/2017
PacBio and GENEWIZ Announce Winner of the 2017 AACR SMRT Grant
Menlo Park, CA and South Plainfield, NJ – Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read sequencing, and GENEWIZ, the leading global genomics service provider, announce that Andrew Ludlow, Ph.D. from the University of Michigan, is the winner of the AACR SMRT® Grant. With this SMRT Grant, Dr. Ludlow will receive Iso-Seq® analysis on the PacBio® Sequel® System at the GENEWIZ laboratory to further his investigation to understand the splicing of transcripts regulated by NOVA1 in lung cancer cells.
South Plainfield, N.J. and Orlando, Fla. (ASHG17, Booth #323) — October 17, 2017 — Leading global genomics service provider, GENEWIZ, launches CLIA Sanger sequencing and new NGS amplicon sequencing, at booth #323 during The American Society of Human Genomics (ASHG) Annual Meeting. ASHG is the largest gathering of human genetics professionals in the world and takes place this October 17-21, 2017 in Orlando.
GENEWIZ TO LAUNCH SINGLE-CELL RNA-SEQ SERVICES AT AACR
South Plainfield, N.J. and Washington, D.C. (AACR17, Booth #3431). — Mar 28, 2017 — Leading global genomics service provider, GENEWIZ, will launch single-cell sequencing during the American Association for Cancer Research (AACR) Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C., April 1-5, 2017. Single-Cell RNA-Seq allows researchers to perform differential gene expression of thousands of cells at the individual level..
GENEWIZ CHOSEN FOR THE INC. 5000 LIST OF FASTEST-GROWING PRIVATE COMPANIES FOR THIRD YEAR IN A ROW
South Plainfield, NJ – November 15, 2016 – Leading global genomics service provider, GENEWIZ, was recently named to the Inc. 5000 list of fastest-growing private companies in the United States for the third consecutive year.
MOUNTAIN VIEW, Calif. — Oct 24, 2016 — Based on its recent analysis of the life science research services market, Frost & Sullivan recognizes GENEWIZ with the 2016 North America Frost & Sullivan Company of the Year Award. GENEWIZ's strategic decisions to reinvest in itself and expand its infrastructure, geographies, and customer channels have enabled it to emerge as a leader in this intensely competitive market. Its recent acquisition of Beckman Coulter Genomics (BCG) and implementation of multiple new genomics platforms demonstrate its commitment to growth and delivering cutting-edge research services using various genomics technologies and techniques.
SOUTH PLAINFIELD, NJ and SAN DIEGO – Oct. 5, 2016 – GENEWIZ, a leading global genomics services provider, today announced it will implement multiple Edico Genome DRAGEN™ Bio-IT processors to accelerate the analysis of massive volumes of genomic data generated by its high-throughput sequencing platforms. GENEWIZ’s already quick turnaround times are expected to be reduced by days for large next-generation sequencing (NGS) data sets, without sacrificing data quality or integrity.
GRAND OPENING OF NEW GENEWIZ CAMBRIDGE LABORATORY
South Plainfield, NJ and Boston – September 27, 2016 - GENEWIZ, a leading global genomics services provider, opened a new flagship laboratory in Cambridge, MA on Wednesday September 21st 2016. The addition of Oligo Synthesis and Plasmid Preparation services to the new Cambridge laboratory enhances the local Boston Sanger DNA sequencing services, providing increased speed and convenience to the customer.10/7/21
Azenta Life Sciences and Cleveland Clinic Celebrate Opening of Biobanking Facility
CLEVELAND, OH and CHELMSFORD, MA – October 7, 2021—Azenta Life Sciences and Cleveland Clinic have opened a new 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus. The two-story biorepository is managed by Azenta Life Sciences, Brooks' recently re-branded life sciences division, and includes ultra-cold and cryogenic storage for researchers at Cleveland Clinic and other institutions. The new facility increases biobanking capacity at Cleveland Clinic and will help accelerate translational research.4/6/21
GENEWIZ Expands High Throughput Sequencing Capabilities with Investment in Multiple Platforms
GENEWIZ Completes Key Gene Synthesis of Zika Virus
Article Authored by GENEWIZ Researchers Published in PLOS ONE
01/11/16
Global Genomics Company, GENEWIZ, Receives Investment
GENEWIZ, a leading global genomics services provider, announced today that it had received an investment to support its growth activities. The terms of the investment were not disclosed. The financing was led by OrbiMed, a healthcare-dedicated investment firm, and participated in by Ampersand Capital Partners and Prime Value Capital Management (PVCM).GENEWIZ Acquires the Genomic Services Business of Beckman Coulter
Leading global genomics service provider, GENEWIZ, has signed a definitive agreement to acquire the genomic services business of Beckman Coulter, which delivers expert genomics sequencing solutions to healthcare businesses, as well as academic and government institutions worldwide (GS).
GENEWIZ Joins Inc. 5000 List of Fastest-growing Private Companies for Second Consecutive Year
GENEWIZ announces partnership with Hy Laboratories Ltd. (hylabs)
04/15/15
GENEWIZ Announces Japanese Expansion & Appointment of Noboru Kagimoto, Japan Country Manager
GENEWIZ Launches Novel Antibody Sequencing Methodology, FuzeSeq™
NJBIZ Ranks GENEWIZ, Inc. #22 Among New Jersey’s 50 Fastest Growing Companies
Leading global genomics service company, GENEWIZ, Inc., was honored by NJBIZ as the 22nd fastest growing company in New Jersey...GENEWIZ, Inc. Completes Key Gene Synthesis of Ebola Virus in Record Time
Leading global genomics service company, GENEWIZ, Inc., was called upon once again by the China CDC...GENEWIZ, Inc. Launches Comprehensive Pharmacogenomics Test PGxOne™
GENEWIZ, Inc. today announced the launch of PGxOne™, a new, comprehensive pharmacogenomics test that provides clinically relevant data for personalized patient treatment...12/18/13
GENEWIZ, Inc. Announces Illumina CSPro™ Certification for Next Generation Sequencing
NJBIZ Ranks GENEWIZ, Inc. #27 Among New Jersey’s Fifty Fastest Growing Companies
GENEWIZ, Inc. was honored by NJBIZ as the 27th fastest growing company in New Jersey...GENEWIZ, Inc. Announces European Expansion & Appointment of Biserka Bacic-Toplek, Sales Executive
GENEWIZ, Inc. today announced expansion of its European operations with the introduction of GENEWIZ Germany...ISBioTech Fall Meeting: Featured Presentation by Dr. Jeffrey A. Shaman
GENEWIZ, Inc. will join the ISBioTech First Fall Meeting next week in Rosslyn, Virginia, with a featured presentation...GENEWIZ, Inc. Launches Ion Proton™ Services as Ion AmpliSeq™ Exome Certified Service Provider
GENEWIZ, Inc. has now become an Ion AmpliSeq™ Exome Certified Service Provider...NJBIZ Honors New Jersey’s 50 Fastest Growing Companies
GENEWIZ, Inc. has been named one of New Jersey’s 50 Fastest Growing Companies...Health Briefs with Terry Bradshaw Features GENEWIZ, Inc.
The producers of Health Briefs with Terry Bradshaw are pleased to announce that GENEWIZ, Inc. will be featured...GENEWIZ, Inc. Announces Collaboration with BeiGene, Ltd.
GENEWIZ, Inc. announced a collaboration with biotechnology company BeiGene...GENEWIZ, Inc. Announces Collaboration with KeyTest Diagnostics
GENEWIZ, Inc. a collaboration with KeyTest Diagnostics to foster...GENEWIZ, Inc. Announces U.S. Expansion with San Francisco Laboratory Opening
GENEWIZ, Inc. announced expansion of its U.S. laboratory facilities...GENEWIZ, Inc. Completes Key Gene Synthesis of H7N9 Influenza Virus in Four Days
Leading global genomics service company, GENEWIZ, Inc., synthesized and delivered key genes of the H7N9 influenza virus in record time...GENEWIZ, Inc. Launches OncoGxOne™ Discovery Cancer Panels
GENEWIZ, Inc., leading global genomics service provider, announced the launch of OncoGxOne™ Discovery cancer panels...GENEWIZ, Inc. Receives CAP Accreditation
Leading global genomics service company, GENEWIZ, Inc., announced accreditation from the College of American Pathologists (CAP)...GENEWIZ, Inc. Expands Next Generation Sequencing Services with Exome Sequencing
GENEWIZ, Inc. announces expansion of their Next Generation Sequencing service portfolio to include exome sequencing...GENEWIZ Highlights Next Generation Sequencing Capabilities at Plant & Animal Genome XXI
GENEWIZ, Inc. is proud to be participating in the Plant & Animal Genome XXI Conference this week in San Diego...Advancing Biotechnology in China: GENEWIZ Gene Synthesis
GENEWIZ, Inc. , is highlighted as a top CRO with entrepreneurial leadership by BioBAY in Nature Biotechnology and Nature Reviews Drug Discovery Biopharma Dealmakers...Nature Biotechnology: Spotlight on GENEWIZ
GENEWIZ, Inc. is featured in this month’s Nature Biotechnology and Nature Reviews Drug Discovery...GENEWIZ, Inc. Expands Next Generation Sequencing Services with Cancer Panels
GENEWIZ, Inc. announces expansion of their Next Generation Sequencing service portfolio to include Cancer Panels...GENEWIZ, Inc. Announces CLIA Certification
GENEWIZ, Inc. received CLIA Licensure and Certificate of Registration from the State of New Jersey...NJBIZ Names GENEWIZ, Inc. 2011 Business of the Year
GENEWIZ, Inc. was named the 2011 Business of the Year by NJBIZ on Monday, December 5...NJBIZ Ranks GENEWIZ, Inc. #28 Among Fifty Fastest Growing Companies
GENEWIZ, Inc. was honored by NJBIZ as one of the 2011 Fifty Fastest Growing Companies on Monday evening, November 14...NJBIZ Honors GENEWIZ, Inc. with New Jersey's Top Businesses and Business Leaders
GENEWIZ, Inc. has been named a finalist for the 2011 NJBIZ Business of the Year Award...GENEWIZ Named Recipient of NJBIA Award for Excellence
GENEWIZ, Inc. was honored by the New Jersey Business & Industry Association 2011 Award for Excellence for Business Expansion...GENEWIZ, Inc. Earns ISO 9001:2008 Quality Management Certification
GENEWIZ, Inc. recently received Quality Management System certification from the International Organization for Standardization (ISO) for their Suzhou, China operation...GENEWIZ Founders Awarded Ernst & Young Entrepreneur Of The Year 2010 in New Jersey
GENEWIZ, Inc., leader in global DNA services, today announced that Dr. Steve Sun, CEO and Dr. Amy Liao, COO, co-founders of GENEWIZ, Inc. received the Ernst & Young Entrepreneur Of The Year 2010 Award in the Service category for New Jersey...GENEWIZ, Inc., Leader in DNA Sequencing & Gene Synthesis, Expands GLP-Compliant Regulatory Services
GENEWIZ, Inc. the largest provider of research-based Sanger DNA sequencing services in the United States, today announced an expansion of its Good Laboratory Practices...GENEWIZ, Inc., Leader in DNA Sequencing & Gene Synthesis, Unveils New Logo
GENEWIZ, Inc. the largest provider of research-based Sanger DNA sequencing in the United States, has introduced an updated logo that emphasizes the company's long-standing commitment to excellence in both science and customer support...DNA Sequencing and Gene Synthesis CRO Announces “GENEWIZ Goes Green” Program
In honor of the 40th Earth Day, GENEWIZ, Inc. announced its “GENEWIZ Goes Green” program, a series of initiatives to reduce environmental impact and encourage employees to undertake additional, ongoing environmentally friendly projects. As a reminder to celebrate Earth Day, GENEWIZ’s website will change from blue to “green” on April 22, for one week...GENEWIZ Adds Gene Synthesis Service to Molecular Biology Service Portfolio
GENEWIZ, Inc., a leading provider of DNA services, announced the expansion of its molecular biology portfolio with the addition of Gene Synthesis services. Gene synthesis provides researchers with a time- and cost-saving alternative to molecular cloning...GENEWIZ Announces DNA Sequencing Webinars
GENEWIZ, Inc., the leading provider of research-based DNA sequencing, has planned a series of webinars in Sepember and October to help biomedical, agricultural...